JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Luca, A.
Right arrow Articles by Conte Camerino, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Luca, A.
Right arrow Articles by Conte Camerino, D.

Vol. 304, Issue 1, 453-463, January 2003

Enhanced Dystrophic Progression in mdx Mice by Exercise and Beneficial Effects of Taurine and Insulin-Like Growth Factor-1

Annamaria De Luca, Sabata Pierno, Antonella Liantonio, Michela Cetrone, Claudia Camerino, Bodvael Fraysse, Massimo Mirabella, Serenella Servidei, Urs T. Rüegg and Diana Conte Camerino

Department of Pharmacobiology, Unit of Pharmacology, University of Bari, Bari, Italy (A.D.L., S.P., A.L., M.C., C.C., B.F., D.C.C.); Institute of Neurology, Faculty of Medicine, A. Gemelli Catholic University, Rome, Italy (M.M., S.S.); and Institute of Pharmacology, School of Pharmacy, University of Lausanne, Lausanne, Switzerland (U.T.R.)

A preclinical screening for prompt-to-use drugs that are safer than steroids and beneficial in Duchenne muscular dystrophy was performed. Compounds able to reduce calcium-induced degeneration (taurine or creatine 10% in chow) or to stimulate regeneration [insulin-like growth factor-1 (IGF-1); 50 or 500 µg/kg s.c.] were administered for 4 to 8 weeks to mdx mice undergoing chronic exercise on a treadmill, a protocol to worsen dystrophy progression. alpha -Methyl-prednisolone (PDN; 1 mg/kg) was used as positive control. The effects were evaluated in vivo on forelimb strength and in vitro electrophysiologically on the macroscopic chloride conductance (gCl), an index of degeneration-regeneration events in mdx muscles, and on the mechanical threshold, a calcium-sensitive index of excitation-contraction coupling. The exercise produced a significant weakness and an impairment of gCl, by further decreasing the already low value of degenerating diaphragm (DIA) and fully hampering the increase of gCl typical of regenerating extensor digitorum longus (EDL) mdx muscle. The already negative voltage threshold for contraction of mdx EDL was also slightly worsened. Taurine > creatine > IGF-1 counteracted the exercise-induced weakness. The amelioration of gCl was drug- and muscle-specific: taurine was effective in EDL, but not in DIA muscle; IGF-1 and PDN were fully restorative in both muscles, whereas creatine was ineffective. An acute effect of IGF-1 on gCl was observed in vitro in untreated, but not in IGF-1-treated exercised mdx muscles. Taurine > PDN > IGF-1, but not creatine, significantly ameliorated the negative threshold voltage values of the EDL fibers. The results predict a potential benefit of taurine and IGF-1 for treating human dystrophy.


0022-3565/03/3041-0453$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
R. Burdi, J.-F. Rolland, B. Fraysse, K. Litvinova, A. Cozzoli, V. Giannuzzi, A. Liantonio, G. M. Camerino, V. Sblendorio, R. F. Capogrosso, et al.
Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests
J Appl Physiol, April 1, 2009; 106(4): 1311 - 1324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. K. McLoon
Focusing on fibrosis: halofuginone-induced functional improvement in the mdx mouse model of Duchenne muscular dystrophy
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1505 - H1507.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Liantonio, V. Giannuzzi, V. Cippone, G. M. Camerino, S. Pierno, and D. C. Camerino
Fluvastatin and Atorvastatin Affect Calcium Homeostasis of Rat Skeletal Muscle Fibers in Vivo and in Vitro by Impairing the Sarcoplasmic Reticulum/Mitochondria Ca2+-Release System
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 626 - 634.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. A. Timmons, O. Larsson, E. Jansson, H. Fischer, T. Gustafsson, P. L. Greenhaff, J. Ridden, J. Rachman, M. Peyrard-Janvid, C. Wahlestedt, et al.
Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy
FASEB J, May 1, 2005; 19(7): 750 - 760.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. De Luca, B. Nico, A. Liantonio, M. P. Didonna, B. Fraysse, S. Pierno, R. Burdi, D. Mangieri, J.-F. Rolland, C. Camerino, et al.
A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice
Am. J. Pathol., February 1, 2005; 166(2): 477 - 489.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Basset, F.-X. Boittin, O. M. Dorchies, J.-Y. Chatton, C. van Breemen, and U. T. Ruegg
Involvement of Inositol 1,4,5-Trisphosphate in Nicotinic Calcium Responses in Dystrophic Myotubes Assessed by Near-plasma Membrane Calcium Measurement
J. Biol. Chem., November 5, 2004; 279(45): 47092 - 47100.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.